Transcription of Molecular Diagnostic Infectious Disease Testing
{{id}} {{{paragraph}}}
Molecular Diagnostic Infectious Disease Testing Page 1 of 23 UnitedHealthcare Medicare Advantage Policy Guideline Approved 01/12/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare Medicare Advantage Policy Guideline Molecular Diagnostic Infectious Disease Testing Guideline Number: Approval Date: January 12, 2022 Terms and Conditions Table of Contents Page Policy Summary .. 1 Applicable Codes .. 3 Questions and Answers .. 19 References .. 19 Guideline History/Revision Information.
simultaneous testing for these pathogens should be rare. Examples include Chlamydophila (Chlamydia) pneumoniae or Bordetella pertussis in combination with rhinovirus, influenza viruses, and respiratory syncytial virus (RSV). The multiplex PCR
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}